Oxygenta Pharmaceutical Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

30.99

60.52

52.03

13.72

20.51

Operating profit

-7.12

1.48

3.84

-7.87

-2.04

Interest

1.49

0.92

1.78

1.09

0.75

Gross profit

-8.59

0.56

2.15

-8.93

-2.78

EPS (Rs)

-8.15

-0.43

2.87

-5.67

-3.19

Other income

0.02

-

0.09

0.03

0.01

Stock adjustment

-4.63

4.55

-6.39

0.59

-1.67

Raw material

28.13

42.67

43.02

14.99

17.75

Power and fuel

-

-

-

-

-

Employee expenses

1.12

0.33

0.73

0.61

0.80

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

13.49

11.50

10.82

5.40

5.67

Provisions made

-

-

-

-

-

Depreciation

2.05

1.59

1.20

1.00

1.02

Taxation

0.20

0.12

0.21

-0.15

-0.24

Net profit / loss

-11.57

-0.61

2.93

-5.79

-3.25

Extra ordinary item

-0.73

0.55

2.19

3.99

0.30

Prior year adjustments

-

-

-

-

-

Equity capital

14.20

14.20

10.20

10.20

10.20

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-22.97

2.44

7.39

-57.36

-9.96

GPM (%)

-27.69

.92

4.13

-64.93

-13.53

NPM (%)

-37.32

-1.01

5.62

-42.10

-15.86